Skip to main content
Premium Trial:

Request an Annual Quote

DNA 2.0 Inks R&D, Japanese Distribution Deal with MediBic

NEW YORK, Dec. 13 (GenomeWeb News) - DNA 2.0 has formed a collaboration with MediBic focused on protein engineering and distribution of gene synthesis in Japan, the company said today.

 

Under the deal, MediBic will work with DNA 2.0 in new product research and development, and will also be the sole Japanese distributor for the company's existing repository of synthesized genes.

 

DNA 2.0 added that the collaboration may be expanded to include internal projects, such as modification of existing bio products and the development of bio products with specialized properties.

 

Additional terms of the arrangement were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.